Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Viral vector constructs for expression of genetic adjuvants activating the CD40 and STING pathways

Viral vector constructs for expression of genetic adjuvants activating the CD40 and STING pathways

US Patent 11674153 · Granted Jun 13, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aptamer-based CAR T-cell switch2025
Aptamer-based CAR T-cell switch2025
Aptamer-based CAR T-cell switch2025
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Lentiviral vectors for expression of hepatitis B virus (HBV) antigens2020
Lentiviral vectors for regulated expression of a chimeric antigen receptor molec2020
Lyophilized lentiviral vector particles, compositions and methods2020
Vectors for molecule delivery to CD11b expressing cells2018
Lentiviral vectors for generating immune responses against human T Lymphotrophic2018